301 related articles for article (PubMed ID: 32896690)
41. Antithrombotic potential of the contact activation pathway.
Schmaier AH
Curr Opin Hematol; 2016 Sep; 23(5):445-52. PubMed ID: 27380557
[TBL] [Abstract][Full Text] [Related]
42. Novel deleterious mutation in the F12 gene in a Korean family with severe coagulation factor XII deficiency.
Kim HJ; Kim HJ; Kwon EH; Lee KO; Park IA; Kim SH
Blood Coagul Fibrinolysis; 2010 Oct; 21(7):683-6. PubMed ID: 20729721
[TBL] [Abstract][Full Text] [Related]
43. FXII regulates the formation of deep vein thrombosis via the PI3K/AKT signaling pathway in mice.
Meng Y; Yin Q; Ma Q; Qin H; Zhang J; Zhang B; Pang H; Tian H
Int J Mol Med; 2021 May; 47(5):. PubMed ID: 33760144
[TBL] [Abstract][Full Text] [Related]
44. [Identification of compound heterozygous variants of F12 gene in a pedigree affected with inherited coagulation factor XII deficiency].
Xie H; Zhang H; Xu M; Zou A; Jin Y; Yang L; Pan J; Wang M
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2020 May; 37(5):519-522. PubMed ID: 32335876
[TBL] [Abstract][Full Text] [Related]
45. Factor XI and XII as antithrombotic targets.
Müller F; Gailani D; Renné T
Curr Opin Hematol; 2011 Sep; 18(5):349-55. PubMed ID: 21730835
[TBL] [Abstract][Full Text] [Related]
46. Mechanism, Functions, and Diagnostic Relevance of FXII Activation by Foreign Surfaces.
Konrath S; Mailer RK; Renné T
Hamostaseologie; 2021 Dec; 41(6):489-501. PubMed ID: 34592776
[TBL] [Abstract][Full Text] [Related]
47. Factor XII Silencing Using siRNA Prevents Thrombus Formation in a Rat Model of Extracorporeal Life Support.
Umei N; Shin S; Lai A; Miller J; Roberts K; Strelkova D; Chaudhary N; Ichiba S; Sakamoto A; Whitehead K; Cook K
ASAIO J; 2023 Jun; 69(6):527-532. PubMed ID: 36728837
[TBL] [Abstract][Full Text] [Related]
48. Plasma levels of bradykinin are suppressed in factor XII-deficient mice.
Iwaki T; Castellino FJ
Thromb Haemost; 2006 Jun; 95(6):1003-10. PubMed ID: 16732380
[TBL] [Abstract][Full Text] [Related]
49. Factor XII regulates the pathological process of thrombus formation on ruptured plaques.
Kuijpers MJ; van der Meijden PE; Feijge MA; Mattheij NJ; May F; Govers-Riemslag J; Meijers JC; Heemskerk JW; Renné T; Cosemans JM
Arterioscler Thromb Vasc Biol; 2014 Aug; 34(8):1674-80. PubMed ID: 24855058
[TBL] [Abstract][Full Text] [Related]
50. Influence of the F12 -4 C>T polymorphism on hemostatic tests.
Corral J; Antón AI; Quiroga T; González-Conejero R; Pereira J; Roldán V; Vicente V; Mezzano D
Blood Coagul Fibrinolysis; 2010 Oct; 21(7):632-9. PubMed ID: 20814302
[TBL] [Abstract][Full Text] [Related]
51. Targeted deletion of murine coagulation factor XII gene-a model for contact phase activation in vivo.
Pauer HU; Renné T; Hemmerlein B; Legler T; Fritzlar S; Adham I; Müller-Esterl W; Emons G; Sancken U; Engel W; Burfeind P
Thromb Haemost; 2004 Sep; 92(3):503-8. PubMed ID: 15351846
[TBL] [Abstract][Full Text] [Related]
52. The factor XIIa blocking antibody 3F7: a safe anticoagulant with anti-inflammatory activities.
Worm M; Köhler EC; Panda R; Long A; Butler LM; Stavrou EX; Nickel KF; Fuchs TA; Renné T
Ann Transl Med; 2015 Oct; 3(17):247. PubMed ID: 26605293
[TBL] [Abstract][Full Text] [Related]
53. Identification of the factor XII contact activation site enables sensitive coagulation diagnostics.
Heestermans M; Naudin C; Mailer RK; Konrath S; Klaetschke K; Jämsä A; Frye M; Deppermann C; Pula G; Kuta P; Friese MA; Gelderblom M; Sickmann A; Preston RJS; Nofer JR; Rose-John S; Butler LM; Salomon O; Stavrou EX; Renné T
Nat Commun; 2021 Sep; 12(1):5596. PubMed ID: 34552086
[TBL] [Abstract][Full Text] [Related]
54. Homozygous missense variant F12 (Gly506Asp) associated with severe factor XII deficiency: a case report.
Aljabry M; Algazlan A; Alsubaie N; Dher SB; Aljabri HS; Alotaibi GS
J Med Case Rep; 2023 Dec; 17(1):504. PubMed ID: 38057855
[TBL] [Abstract][Full Text] [Related]
55. A role for factor XIIa-mediated factor XI activation in thrombus formation in vivo.
Cheng Q; Tucker EI; Pine MS; Sisler I; Matafonov A; Sun MF; White-Adams TC; Smith SA; Hanson SR; McCarty OJ; Renné T; Gruber A; Gailani D
Blood; 2010 Nov; 116(19):3981-9. PubMed ID: 20634381
[TBL] [Abstract][Full Text] [Related]
56. Platelet polyphosphates: the nexus of primary and secondary hemostasis.
Müller F; Renné T
Scand J Clin Lab Invest; 2011 Apr; 71(2):82-6. PubMed ID: 21385010
[TBL] [Abstract][Full Text] [Related]
57. Use of "C9/11 Mismatch" Control siRNA Reveals Sequence-Related Off-Target Effect on Coagulation of an siRNA Targeting Mouse Coagulation Factor XII.
Heestermans M; de Jong A; van Tilburg S; Reitsma PH; Versteeg HH; Spronk HM; van Vlijmen BJM
Nucleic Acid Ther; 2019 Aug; 29(4):218-223. PubMed ID: 31063435
[TBL] [Abstract][Full Text] [Related]
58. Factor XII Activation Promotes Platelet Consumption in the Presence of Bacterial-Type Long-Chain Polyphosphate In Vitro and In Vivo.
Zilberman-Rudenko J; Reitsma SE; Puy C; Rigg RA; Smith SA; Tucker EI; Silasi R; Merkulova A; McCrae KR; Maas C; Urbanus RT; Gailani D; Morrissey JH; Gruber A; Lupu F; Schmaier AH; McCarty OJT
Arterioscler Thromb Vasc Biol; 2018 Aug; 38(8):1748-1760. PubMed ID: 30354195
[TBL] [Abstract][Full Text] [Related]
59. Mouse venous thrombosis upon silencing of anticoagulants depends on tissue factor and platelets, not FXII or neutrophils.
Heestermans M; Salloum-Asfar S; Streef T; Laghmani EH; Salvatori D; Luken BM; Zeerleder SS; Spronk HMH; Korporaal SJ; Kirchhofer D; Wagenaar GTM; Versteeg HH; Reitsma PH; Renné T; van Vlijmen BJM
Blood; 2019 May; 133(19):2090-2099. PubMed ID: 30898865
[TBL] [Abstract][Full Text] [Related]
60. Novel roles for factor XII-driven plasma contact activation system.
Müller F; Renné T
Curr Opin Hematol; 2008 Sep; 15(5):516-21. PubMed ID: 18695377
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
